Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

(2015) Ian J Neeland et al.   Diabetes & Vascular Disease Research

Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults

(2015) Ian J. Neeland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Index of central obesity as a parameter to replace waist circumference for the definition of metabolic syndrome in predicting cardiovascular disease

(2014) Wenshu Luo et al.   Journal of Cardiovascular Medicine

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial

(2014) Martin Ridderstråle et al.   Lancet Diabetes & Endocrinology

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review

(2014) Janet B. McGill   Diabetes Therapy

Relation of Regional Fat Distribution to Left Ventricular Structure and Function

(2013) Ian J. Neeland et al.   Circulation-Cardiovascular Imaging

Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary Disease

(2013) Thais Coutinho et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Body Fat Distribution and Risk of Cardiovascular Disease

(2012) Jean-Pierre Després   CIRCULATION

Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults

(2012) Ian J. Neeland et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Index of Central Obesity Is Better Than Waist Circumference in Defining Metabolic Syndrome

(2009) Rakesh M. Parikh et al.   Metabolic Syndrome and Related Disorders

Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis

(2008) Crystal Man Ying Lee et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY